SUTENT-12.5mg,-25mg,-37.5mg-and-50mg-Hard-Capsules-1000x700

SUTENT 12.5mg, 25mg, 37.5mg and 50mg Hard Capsules

SUTENT 12.5mg, 25mg, 37.5mg and 50mg Hard Capsules

1091total visits,2visits today

Product Description

Pill imprint Pfizer STN 12.5 mg has been identified as Sutent 12.5 mg.

Sutent is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

1091total visits,2visits today

Additional Information

Generic Name: sunitinib

1091total visits,2visits today

Reviews

There are no reviews yet.

Be the first to review “SUTENT 12.5mg, 25mg, 37.5mg and 50mg Hard Capsules”